Top Markets
#1 Nesa Nesa +797.03%
#2 Cortex Cortex +68.91%
#3 Merlin's Seal BTC Merlin's Seal BTC +45.76%
#4 QuantixAI QuantixAI +40.81%
#5 Pons Pons +25.08%
#6 EXOD EXOD +22.78%
#7 Instadapp Instadapp +20.00%
#8 Renzo Restaked LST Renzo Restaked LST +10.38%
#9 Fartcoin Fartcoin +9.77%
#10 PondCoin PondCoin +8.97%
Coin of the day
Nesa Nesa
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
UnicoCell Biomed Co., Ltd. UnicoCell Biomed Co., Ltd.

UnicoCell Biomed Co., Ltd.

6794
Kedudukan dalam Saham #19525
UnicoCell Biomed Co., Ltd., a Taiwanese enterprise, specializes in the... UnicoCell Biomed Co., Ltd., a Taiwanese enterprise, specializes in the research, development, and application of stem cell-based pharmaceuticals, advanced cell therapy techniques, and regenerative medical solutions. Their flagship product, ELIXCYTE, is presently undergoing Phase 2 clinical trials, targeting both osteoarthritis and chronic kidney disease. Beyond therapeutics, the company also offers UnicoVial, a specialized cryopreservation and drug containment system designed for cell therapy products, and provides a range of related testing services.
Harga Saham
$2.54
Modal Pasaran
$161.89M
Perubahan (1 hari)
5.96%
Perubahan (1 tahun)
1.63%
Negara
TW
Perdagangan UnicoCell Biomed Co., Ltd. (6794)

Kategori

Healthcare
Sejarah hasil dividen untuk UnicoCell Biomed Co., Ltd. (6794)
Hasil dividen (TTM) bagi UnicoCell Biomed Co., Ltd. (simbol saham: 6794) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk UnicoCell Biomed Co., Ltd. (6794) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
Syarikat Hasil Dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH